Global Peptide Therapeutics Market is Predicted to Reach US$ 57,166.5 Million by The End of 2027, with a Value of US$ 23,319.3 Million

-
Peptide Therapeutics
Peptide Therapeutics

Peptides are potent signalling molecules that bind to certain cell surface receptors and cause intracellular actions. Over the forecast period, the worldwide Peptide Therapeutics Market is expected to rise due to the rising prevalence of metabolic diseases and cardiovascular disorders (CVDs). According to the American Heart Association's Heart Disease and Stroke Statistics 2018, about 92.1 million adults in the United States suffer from CVD or stroke-related complications.

Furthermore, rising healthcare spending is likely to support market expansion. According to the Centers for Medicare & Medicaid Services (CMS), health spending in the United States is expected to expand at a 5.5 percent annual pace from 2018 to 2027, reaching almost US$ 6.0 trillion. The Global Peptide Therapeutics Market is projected to be hampered by natural peptides' poor chemical and physical stability, as well as their short circulating plasma half-life.

Furthermore, the presence of strict safety requirements is limiting market expansion. Peptide therapies, for example, require a better regulatory framework because they treat various clinical disorders; the regulatory environment is predicted to improve by 2020. Furthermore, R&D in microbiome research is likely to enhance the market for peptide therapies. Researchers from Israel's Chaim Sheba Medical Center stated in January 2020 that high fructose consumption caused metabolic alterations and dysbiosis in rats, and that these changes are likely independent of a specific microbiome composition

The development of novel peptides is projected to provide attractive growth prospects for market players. CohBar, Inc., for example, announced additional preclinical findings in December 2019 that demonstrated the therapeutic potential of a unique CohBar peptide in a preclinical model of Idiopathic Pulmonary Fibrosis (IPF). New platforms for developing next-generation protein or peptide therapies are becoming more popular in the Peptide Therapeutics Market. For example, Xenetic Biosciences, Inc. stated in January 2020 that the data from SHP656 ("PSA-recombinant Factor VIII", "PSA-rFVIII"completed )'s Phase 1/2 clinical research had been published in the journal Haemophilia. PolyXen technology, a patent-protected platform technology for developing next-generation protein or peptide therapies, was used in the study.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more